Among the 32 studies that were included in this investigation, only 3 analyzed the presence of GSTM1, either in Asian or Caucasian populations, while the data regarding the overall survival in CRC patients were actually lacking. This evidence concerns the gene GSTM1 and colorectal carcinoma.